• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 476729 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1419051525 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1419051525 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Traders Get Bullish on Shares of Cerus, Shares Up 5.3% (CERS)

Published on Thu, 04/11/2013 - 12:25
By Robert Cotter

Cerus (NASDAQ:CERS) is one of today's best performing low-priced stocks, up 5.3% to $4.78 on 1.1x average daily volume. Cerus has traded 780,000 shares thus far today, vs. average volume of 709,000 shares per day. The stock has outperformed the Dow (5.3% to the Dow's 0.5%) and outperformed the S&P 500 (5.3% to the S&P's 0.5%) during today's trading.

Over the past year, Cerus has traded in a range of $2.68 to $4.82 and is now at $4.78, 78% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.5% while the 50-day MA has advanced 2.3%.

Cerus has overhead space with shares priced $4.78, or 23.5% below the average consensus analyst price target of $6.25. The stock should find initial support at its 50-day moving average (MA) of $3.79 and further support at its 200-day MA of $3.38.

Cerus Corporation develops systems designed to enhance the safety of blood transfusions. The Company's systems inactivate pathogens in blood components and inactivate white blood cells, which are responsible for a variety of adverse transfusion reactions. Cerus' platform technologies prevent viral, bacterial, and cellular replication.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Shares of Wells Fargo Rise to a New 52-W...

Wells Fargo (NYSE:WFC) traded at a new 52-week high today of $55.42. Approximately 20. ...

Watch for Continued Gains in Shares of W...

Wisconsin Energy (NYSE:WEC) traded today at a new 52-week high of $52.50. So far today ...

Recent 52-Week High Exceeded in Shares o...

Shares of Western Digital (NYSE:WDC) traded today at $114.69, breaking its 52-week high ...

WellCare Health Plans: The Winning Strea...

Shares of WellCare Health Plans (NYSE:WCG) traded at a new 52-week high today of $80.95 ...

Vertex Pharmaceuticals Looks to Continue...

Vertex Pharmaceuticals (NASDAQ:VRTX) traded at a new 52-week high today of $123.82. Th ...

Shares of Vornado Realty Trust Rise Abov...

Shares of Vornado Realty Trust (NYSE:VNO) traded today at $117.37, breaking its 52-week ...

US Bancorp Looks to Continue to Trade Ab...

Shares of US Bancorp (NYSE:USB) traded today at $45.54, breaking its 52-week high. So ...

United Parcel Service Looks to Continue ...

United Parcel Service (NYSE:UPS) traded today at a new 52-week high of $111.99. So far ...